From Barchart: 2025-05-17 13:00:00

Mad Money host Jim Cramer recommends buying shares of pharmaceutical company Eli Lilly & Co., citing its strong performance compared to a key competitor. This positive evaluation is based on the company’s recent financial results and market trends. Investors are advised to consider adding Eli Lilly & Co. to their portfolios for potential growth and profitability. Cramer’s endorsement highlights the company’s competitive edge in the pharmaceutical industry and its promising outlook for future success.



Read more at Barchart: Jim Cramer Says You Should Buy This ‘Strong Buy’ Stock ‘Hand Over Fist’